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ABSTRACT
Background: TENS is a non-invasive, safe nerve stimulation intended to reduce pain, both acute 
and chronic. However there is controversy regarding its effectiveness in relieving this pain.
Objective: This study was designed to establish the effectiveness of TENS compared with NSAID 
drugs in the management of patient with post operation pain due to gynaecological conditions 
(Hysterectomy/myomectomy) and caesarean section.
Methods: Thirty (30) patients with diagnosis of fibroid for hysterectomy/myomectomy, caesarian 
section and surgical procedures were assigned into three groups of 10 patients each.
Group 1: treated with NSAID drugs
Group 2: treated with NSAID drugs with TENS
Group 3: treated with TENS
Pain intensity was assessed using the Visual Analogue Scale (VAS) at the beginning pre-treatment 
and at the end of every week for three uninterrupted weeks in each group and compared.
Results: The groups were comparable with VAS scores over three weeks post operative period. A 
statistically significant difference was found in all the three groups between the mean pre-treatment 
and post-treatment pain intensities for the three weeks (p=0.00). The mean VAS score decreased 
with each groups; however the mean VAS scores of TENS with drug decreased significantly 
compared with drug and TENS alone groups (p<0.05). Although NSAID alone controlled the pains 
better than TENS alone this superiority was not appreciated until the third week (p= 0.01).
Conclusion: We conclude that TENS with NSAID was more effective than either NSAID or TENS 
alone in the management of post operation pain
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pain as “As unpleasant sensory and emotional 
experience associated with actual or potential 
tissue damage or described in terms of such 
damage1. Postoperative pain is both distressing 
and detrimental for the patients. The 
management of postoperative pain involves 
assessment of the pain in terms of intensity at 
rest and activity associated pain, treatment by 
pharmacological and non-pharmacological 
means as well as monitoring induced side-
effects2.
Transcutaneous electric nerve stimulation 
(TENS) has been established to be effective in 
the management of many painful conditions like 
dysmenrrhoea, labour pain, dental pain and 
general acute muscular skeletal pain3 but there 
is controversy on the effectiveness of TENS on 
chronic painful conditions, specifically joint 
pain.
The clinical application of TENS today evolved 
from Shealy's developmental work on neuro-
modulation techniques in the 1960s4which is 
underpinned by the 'gate control theory'5. It is 
thought that pain may be alleviated by using 
peripheral stimulation, such as rubbing, 
vibration, heat or cold, or, as in the case of 
TENS, electrical stimulation directly over the 
area of pain. This peripheral stimulation induces 
electrical activity which inhibits the brain's 
perception of pain.
The 'gate control theory' is based on the principle 
that there is a gateway in the dorsal horn of the 
spinal cord, which somehow controls or 
regulates the flow of pain messages that are then 
sent to (ascending) and from (descending) 
higher levels of the brain for central processing, 
thus reducing the perception of pain. Other 
postulated mechanisms of the pain relief 
mediated by TENS include the promotion of 
endorphin release in the brain6 and local 
dilatation of blood vessels in injured tissue7. 
Treatment with TENS has the advantages of 
being controlled by the patient and does not 
involve the use of medication. TENS is 
inexpensive and virtually without risk, and there 
are few contraindications. However, NSAID's 
are heterogeneous groups of agents that mediate 
anti-inflamatory, analgesic, antipyretic and 
platelet inhibitory effects. NSAID's are effective 
in the postoperative setting and their usefulness 
may be limited due to their tendency to cause 
gastro-intestinal and surgical site haemorrhage 
and renal failure especially in high risk 
patients2.This study was intended to establish 
the effectiveness of TENS compared with 
NSAID drugs in the management of patient with 
post operation pain due to gynaecological 
conditions (Hysterectomy/myomectomy) and 
caesarean section.
MATERIALS AND METHODS
Thirty (30) patients with diagnosis of fibroids 
and obstructed labour. They were aged between 
34-55 years. They were patients referred for 
p h y s i o t h e r a p y  a t  U I T H .  P r i o r  t o  
experimentation, subjects were informed of the 
experimental procedures and each volunteered, 
to be included into the study by signing an 
informed consent. The subjects were assigned 
into three groups of ten  each.
Inclusion: subjects with post operation 
conditions like (Hysterectomy, myomectomy 
ceaserian section e.t.c) were included, whereas, 
subjects with other post operation conditions 
were excluded.
Instrumentation:
TENS machine (model promedics)
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General Description
The stimulate N604SD Timer TENS is a battery 
operated pulse generator that sends electrical 
impulses electrodes to the body and reach the 
nerves causing pain. The device is provided 
with two controllable output channel, each 
independent of each other. An electrodes pair 
can be connected to each output channel.
The electronics of the stimate N603SD TENS 
creates electrical impulses whose intensity, 
duration, number per second and modulation 
may be altered with the control switches. Dial 
controls are very easy to use and the slide cover 
prevents accidental changes in the setting.
The TENS unit sends comfortable impulses 
through the skin that stimulate the nerve(s) in 
the treatment area. In many cases, this 
stimulation will greatly reduce or eliminate the 
pain sensation the patient feels. Pain relief 
varies by individual patient, mode selected 
therapy and the type of pain.
In many patients, the reduction or elimination of 
pain last longer than the actual period of 
stimulation (sometimes as much as three-four 
times longer) in others, pain is only modified 
while stimulation actually occurs.
Research Design: We compared pain intensity 
in all the three groups at the beginning of the 
study (Pre-treatment) at the end of every 
treatment week for the duration of the study, 
which was three uninterrupted weeks. All 
subjects were treated daily for three weeks.
Experimental Procedures 
A brief history of the origin and duration of the 
pain and any associated problems were 
conducted.
Assessment and examination of the patients 
was conducted to establish the painful areas. 
Palpation and localization of the painful area 
was by mild pressure via the thumb on the 
surgical site.
Intensity of pain was rated using the Visual 
Analogue Scale (VAS), numerically [8] and 
verbally using the modified verbal rating scale 
[9]
Drug therapy was administered for the selected 
twenty patients
TENS machine with a set of 4- self Adhesive 
electrodes were used. The unit delivered a 
rectangular monophase DC wave form of 
IMSEE duration at a rate of 100HZ. Electrodes 
were applied to 4 points on the painful area and 
the TENS was applied for 10 minutes.
All subjects in this study followed the 
experimental procedure and were instructed to 
report any medical problem immediately.
RESULTS
A total of thirty subjects in three groups of ten 
were used for the study. The subjects were 
randomized into three experimental groups- 
TENS with drug, Drug alone and TENS alone. 
The mean ages of the subjects were 44.50±8.11, 
47.30±6.86, 44.80±5.09 for subjects in TENS 
with drug, Drug alone and TENS alone 
respectively. The mean Body Mass Index (BMI) 
for the TENS with Drug group was 32.6±7.86 
kg/m2, while it was found to be 36.4±8.34kg/m2 
and 34.3±6.38 kg/m2 for the Drug alone and 
TENS alone group respectively.(table 1).
The mean pre-treatment pain intensity was 
found to be 8.60±0.69, 9.30±0.48, and 9.20±0.63 
for the TENS with Drug, Drug alone and TENS 
alone respectively. Also, the mean post-
treatment intensity for the TENS with Drug 
group was found to be 6.90±0.99, 4.10±1.19 and 
2.10±0.74 for the first to the third weeks 
respectively. It was also found to be 8.00±0.67, 
5.40±0.52 and 3.10±0.74 for the Drug alone 
group for the three weeks respectively. For the 
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TENS alone group, the mean post-treatment 
intensity was 7.60±0.52, 5.90±0.88 and 
4.40±1.01 for the three weeks respectively. 
There was a statistically significant difference 
between the mean pre-treatment pain intensities 
of the TENS with drug and drug alone, TENS 
with drug and TENS groups with p values of 
0.02 and 0.05 respectively. However, the 
difference was not statistically significant 
between the mean pre-treatment intensities of 
the Drug alone and TENS alone groups with a p 
value of 0.20. (table 2)
The mean of the difference between the pre-
treatment pain intensity and the post treatment 
pain intensities for the TENS with drug group 
was 1.70±0.678, 4.50±0.85 and 6.50±0.97 for 
the first three weeks respectively. However, 
while the mean of the difference between the 
pre-treatment pain intensity and the post 
treatment pain intensities was found to be 
1.30±0.48, 3.90±0.57, and 6.20±1.03 for the 
Drug alone group for the three weeks 
respectively, it was 1.60±0.52, 3.30±0.82 and 
4.80±1.03 for the TENS alone group for the 
three weeks respectively. Also, a statistically 
significant difference was found in all the three 
groups between the mean pre-treatment pain 
intensities and the mean post-treatment pain 
intensities for the three weeks with p values of 
0.000 each. (table 3).
The mean post treatment pain intensities were 
also compared in all the three groups. For the 
TENS with Drug and Drug alone, a statistically 
significant difference was found between their 
mean post treatment pain intensities for all the 
three weeks with p values of 0.01, 0.01 and 0.01 
respectively. Also, similar finding was 
replicated between the mean post treatment pain 
intensities for the TENS with Drug and TENS 
group with p values of 0.05, 0.00 and 0.01 for the 
three weeks respectively. 
However, this was not so when the mean post 
treatment pain intensities of Drug alone and 
TENS alone were compared. For the first two 
weeks post treatment, there was no statistically 
significant difference between their mean post 
treatment pain intensities with p values of 0.22 
and 0.20 respectively. However, a significant 
difference was found between their mean post 
treatment pain intensities at the third week post 
treatment with p value of 0.01. (table 4).
DISCUSSION
Postoperative pain involve and worries the 
multidisplinary team as far as choosing the  best 
way of decreasing it, especially because its 
presence can mask postoperative surgical 
complications and hinder patient recovery10. In 
this study TENS was found to be effective in 
relieving post operative pain as evidence by a 
statistically significant difference between the 
mean pre-treatment pain intensities and the 
mean post-treatment pain intensities for the 
three weeks. This is similar to finding obtained 
from previous studies11-13.  Also, the acute 
pain management guideline panel of the Agency 
for Health Care Policy and Research (AHCPR) 
in the United State of America concluded that 
TENS was effective in reducing post operative 
pain and improving function14.
 On the contrary, Reeve et al15, Carroll et al16 
and Bandolier et al17 concluded that TENS did 
not produce significant post operative pain relief 
in their series. This finding was corroborated by 
the report of the Australian and New Zealand 
College of Anaesthetists (ANZCA) and Faculty 
of Pain's Medicine Acute Pain Management 
which states that 'there is limited evidence that 
physical therapies [such as TENS] help acute 
pain18
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NSAID was also found to relief post operative 
pain significantly and has shown to be superior 
to TENS most especially at the third week. 
However, the possibility of development of 
undesirable side effects following its prolonged 
use will limit its wider application in relieving 
of post operative pain2.
 It was also clearly demonstrated in this study 
that combination of TENS and NSAID's was 
more effective than either TENS and NSAID's 
alone. This agrees with the findings of Bjordal 
et al19. This is also inconsonance with the 
report of the Royal College of England and the 
Faculty of Anaesthetists Working Party on Pain 
after surgery with the conclusion that TENS 
was not effective as a stand-alone treatment for 
moderate to severe post operative pain20.
In conclusion, there is credible evidence that 
TENS reduce postoperative pain though less 
than NSAID. The use of TENS with NSAID 
was more effective than either TENS or NSAID 
alone. Further research is required to elucidate 
this finding since the sample size of the study is 
limited. 
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Pre treatment pain intensity 9.20 0.63
Post treatment pain intensity
1st week 7.60 0.52
2nd week 5.90
Table 1: Mean of the Parameters of subjects in 
the three experimental groups 
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Table 2: Comparing Mean of Pre-treatment pain 
intensity in the three experimental groups
Table 4: Comparison of Mean of Post treatment 
pain intensity in all the groups
Variable TENS with drug Drug t df p 
Value
Pre treatment pain intensity
Mean    8.60 9.30
Standard deviation











Pre treatment pain intensity
 
Mean     8.60  9.20  
Standard deviation












Pre treatment pain intensity
Mean                                  9.30 9.20
Standard deviation 0.48 0.63 0.399 18
0.1995                  
Table 3: Comparing Mean of Pre and Post 
treatment pain intensity in all the groups
Variable                                           TENS with drug d  t df p value
Pre treatment pain intensity
Mean 8.60
Standard deviation 0.69
Post treatment pain intensity(1st week)
Mean 6.90  1.70
Standard deviation 0.99 0.678 7.965 90.000     
Post treatment pain intensity(2nd week)
Mean 4.10 4.50
Standard dev iation 1.19 0.85 16.745
90.000
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Post treatment pain intensity(2nd week)
Mean 5.40 3.90
Standard deviation 0.52 0.57   21.726       90.000   
Standard deviation 0.69
Post treatment pain intensity(1st week)
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Standard deviation 0.99 0.678 7.965 90.000     
Post treatment pain intensity(2nd week)
Mean 4.10 4.50
Standard dev iation



























Post treatment pain in tensity(1st week)
Mean 8.00 1.30  
Standard devi ation 0.67 0.48 8.510 90.000
Post treatment pain intensity(2nd week)
Mean 5.40 3.90
Standard deviation 0.52 0.57   21.726       90.000   
Post treatment pain intensity(3rd week)
Mean 3.10 6.20
Standard deviation 0.74 1.03    18.984       90.000
TENS
Variable TENS with Drug Drug t df p value
Post treatment pain intensity(1st wk)
Mean 6.90 8.00
Standard deviation 0.99 0.67 -2.909 18        0.014
Post treatment pain intensity(2nd wk)
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-3.846 18       0.001
Post treatment pain intensity(3rd wk)
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Post treatment pain intensity(1st wk)
 
Mean 8.00 7.60
Standard deviation 0.67 0.52 1.491 18        0.223
Post treatment pain intensity(2nd wk)
Mean 5.40 5.90
Standard deviation 0.52 0.88 -1.547 18         0.202
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